Today, we’re going on a journey to explore the estimated Gland Pharma Share Price Target for the years 2023 to 2050. We will use our Research and the company’s growth prospects to make a prediction. By the end of our journey, you will have a better understanding of the expected Gland Pharma Share Price Target.
Gland Pharma Limited is a leading pharmaceutical company in India that specializes in the development, manufacturing, and marketing of injectables. The company was founded in 1978 and is headquartered in Hyderabad, Telangana, India. The current CEO of Gland Pharma is Srinivas Sadu.
In November 2020, Gland Pharma went public with an initial public offering (IPO) that raised over $870 million. The IPO was one of the largest in India’s pharmaceutical sector and was oversubscribed by more than 2.06 times.
The company’s services include the development, manufacturing, and marketing of a wide range of injectables, including vials, ampoules, pre-filled syringes, lyophilized products, and dry powders. Gland Pharma has a strong focus on research and development and has a number of products in its pipeline.
Gland Pharma has a presence in several countries around the world, including the United States, Canada, Europe, Australia, and South Africa. The company has manufacturing facilities in India and has received several certifications from regulatory authorities, including the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Australian Therapeutic Goods Administration (TGA).
Overview of Gland Pharma
| Name | Gland Pharma Limited |
| Symbol | GLAND |
| Industry | Pharmaceuticals |
| Founded | 1978 |
| CEO | Srinivas Sadu |
| Headquarters | Hyderabad, India |
| Exchange | NSE, BSE |
| Country | India |
| Locations | Hyderabad, Telangana, India |
| Website | glandpharma.com |
| Profile | Gland_Pharma |
We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Gland Pharma Share price target for 2023, 2025, 2030 to 2050.
Keep an eye on Gland Pharma’s share price today with real-time updates, and examine its performance on the stock market through comprehensive charts that display the fluctuations in Gland Pharma’s stock price.
Additionally, we will also take into analyst recommendations from various brokerage firms, including target high price, target low price, mean recommendation, and key recommendation at the end of the article.
Above, the chart presents historical prices for Gland Pharma stock, illustrating its trending behavior. Below, the table provides detailed data on the stock’s open, high, low, and close prices, offering a comprehensive perspective for stock analysis.
Brokerage Firms
An effective method for evaluating the Gland Pharma share price Target is by examining research reports and analyses conducted by reputable financial institutions and brokerage firms.
| DATE | AUTHOR | TARGET | TYPE |
|---|---|---|---|
| 09 AUG 2023 | Axis Direct | 1620.00 |
Hold
|
| 07 AUG 2023 | Motilal Oswal | 1560.00 |
Buy
|
| 19 MAY 2023 | Axis Direct | 1400.00 |
Hold
|
| 25 JAN 2023 | Axis Direct | 1500.00 |
Hold
|
| 23 JAN 2023 | Motilal Oswal | 1700.00 |
Buy
|
Fundamentals of Gland Pharma
The fundamental analysis of Gland Pharma Limited focuses on key factors to better understand the company’s valuation.
We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Gland Pharma price target for 2023, 2025 to 2030, based on our Research knowledge and forecasting.
For the year 2023, we forecast that the minimum share price target for Gland Pharma will be ₹1900, while the maximum share price target will be ₹2200. This is based on the company’s strong financial performance in Q1’FY24, which showed a significant increase in revenue and net profit compared to the previous year. Additionally, the company’s growth and expansion plans, as well as its research and development efforts, are expected to drive future growth.
Looking ahead to 2024, we forecast that the minimum share price target for Gland Pharma will be ₹2200, while the maximum share price target will be ₹2500. This is based on the company’s continued growth and expansion plans, as well as its focus on developing new products and technologies to meet the evolving needs of the healthcare industry.
For the year 2025, we forecast that the minimum share price target for Gland Pharma will be ₹2500, while the maximum share price target will be ₹2800. This is based on the company’s strong financial performance in recent years, as well as its continued focus on research and development and expansion into new markets.
For the year 2027, we forecast that the minimum share price target for Gland Pharma will be ₹3100, while the maximum share price target will be ₹3400. This is based on the company’s strong financial performance in recent years, as well as its continued focus on research and development and expansion into new markets.
Looking ahead to 2030, we forecast that the minimum share price target for Gland Pharma will be ₹4000, while the maximum share price target will be ₹4500. This is based on the company’s continued growth and expansion plans, as well as its focus on developing new products and technologies to meet the evolving needs of the healthcare industry. Additionally, the company’s strong financial performance and market position are expected to drive future growth.
For the year 2035, we forecast that the minimum share price target for Gland Pharma will be ₹5500, while the maximum share price target will be ₹6000. This is based on the company’s continued focus on research and development, as well as its expansion into new markets and the development of new products and technologies. Additionally, the company’s strong financial performance and market position are expected to drive future growth.
For the year 2050, we forecast that the minimum share price target for Gland Pharma will be ₹10,000, while the maximum share price target will be ₹12,000. This is based on the company’s continued focus on research and development, as well as its expansion into new markets and the development of new products and technologies. Additionally, the company’s strong financial performance and market position are expected to drive future growth.
Analyst Recommendations
Gland Pharma Buy or Sell
Daily Low / High
How to Buy Gland Pharma Stock
- Click on the “Open an Account“
- Fill in the required details
- Complete the verifying your identity
- Login to Your Account
- Search for Gland Pharma
- Place an Order.
| Telegram Channel | 👉 Click Here ☑ |
| Facebook Page | 👉 Click Here ☑ |
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2023 | ₹1900 | ₹2200 |
| 2024 | ₹2200 | ₹2500 |
| 2025 | ₹2500 | ₹2800 |
| 2026 | ₹2800 | ₹3100 |
| 2027 | ₹3100 | ₹3400 |
| 2030 | ₹4000 | ₹4500 |
| 2035 | ₹5500 | ₹6000 |
| 2040 | ₹7000 | ₹7500 |
| 2050 | ₹10,000 | ₹12,000 |
– As of 16 September 2023, the current share price of Gland Pharma is ₹1,705 Check out today’s current share price.
– Based on our analysis, the maximum share price target for Gland Pharma in 2023 could be ₹2200.
– According to Google historical data, the price of Gland Pharma on 20 Nov 2020 was ₹1819.55.
To stay updated with the latest information related to the stock market and receive live stock market updates, follow Sharedhan and stay connected with us. Check out Today’s Share Market Open or Closed India.
I would like to remind you that I am not authorized by SEBI to provide any financial advice or recommendations. As you know, Share price prediction is not an exact science, That’s why I am conducting in-depth research and using different AI tools to predict share prices. My purpose is only educational, and I am using AI to see what the future of the stock might look like.
Disclaimer– These Share Price Targets for “Gland Pharma Share Price Target” are only provided for informational purposes only. It does not constitute a recommendation to buy, sell, or hold Gland Pharma stock. Investors should conduct their own research and analysis and consult with financial experts before making any investment decisions— Sharedhan.com
